Published on
HCV Guidance
(
https://www.hcvguidelines.org
)
Home
>
Home
> Contents
Welcome and Methods
Introduction
Methods
Table 1. Summary of the Process and Methods for the Guidance Development
Table 2. Rating System Used to Rate Level of Evidence and Strength of Recommendation
Table 3. Commonly Used Abbreviations
Test, Evaluate, Monitor
Testing, Evaluation, and Monitoring of Hepatitis C
HCV Testing and Linkage to Care
When and in Whom to Initiate HCV Therapy
Overview of Cost, Reimbursement, and Cost-Effectiveness Considerations for Hepatitis C Treatment Regimens
Monitoring Patients Who Are Starting HCV Treatment, Are on Treatment, or Have Completed Therapy
HCV Resistance Primer
Treatment-Naive
Initial Treatment of Adults with HCV Infection
Simplified HCV Treatment* for Treatment-Naive Adults Without Cirrhosis
Simplified HCV Treatment Algorithm for Treatment-Naive Adults With Compensated Cirrhosis
Treatment-Naive Genotype 1
Treatment-Naive Genotype 1a Without Cirrhosis
Treatment-Naive Genotype 1a With Compensated Cirrhosis
Treatment-Naive Genotype 1b Without Cirrhosis
Treatment-Naive Genotype 1b With Compensated Cirrhosis
Treatment-Naive Genotype 2
Treatment-Naive Genotype 2 Without Cirrhosis
Treatment-Naive Genotype 2 With Compensated Cirrhosis
Treatment-Naive Genotype 3
Treatment-Naive Genotype 3 Without Cirrhosis
Treatment-Naive Genotype 3 With Compensated Cirrhosis
Treatment-Naive Genotype 4
Treatment-Naive Genotype 4 Without Cirrhosis
Treatment-Naive Genotype 4 With Compensated Cirrhosis
Treatment-Naive Genotype 5 or 6
Treatment-Experienced
Retreatment of Persons in Whom Prior Therapy Failed
Sofosbuvir-Based and Elbasvir/Grazoprevir Treatment Failures
Glecaprevir/Pibrentasvir Treatment Failures
Multiple DAA Treatment Failures (All Genotypes), Including Sofosbuvir/Velpatasvir/Voxilaprevir or Sofosbuvir Plus Glecaprevir/Pibrentasvir
Unique Populations
Management of Unique & Key Populations With HCV Infection
Patients With HIV/HCV Coinfection
Patients With Decompensated Cirrhosis
Patients Who Develop Recurrent HCV Infection Post Liver Transplantation
Treatment of HCV-Uninfected Transplant Recipients Receiving Organs From HCV-Viremic Donors
Patients with Renal Impairment
Kidney Transplant Patients
Management of Acute HCV Infection
HCV in Pregnancy
HCV in Children
Management of Key Populations With Chronic HCV Infection
Key Populations: Identification and Management of HCV in People Who Inject Drugs
HCV in Key Populations: Men Who Have Sex With Men
HCV Testing and Treatment in Correctional Settings
